San Francisco -- Medizone International, the San Francisco-based developer of a technology system used to decontaminate and sterilize operating rooms, intensive care units and other critical infrastructure, said on Thursday it has landed a $10 million funding commitment from Illinois-based Mammoth Corp. Under the deal, Mammoth will purchase the company's stock at a 25% discount, up to $500,000 at a time. Medizone will determine when and how much of the commitment it wants to utilize. "Previously, Medizone has traditionally been funded by private placements of restricted securities to accredited investors," said Medizone CEO Edwin Marshall, adding his company plans to use the new resource "to finalize our various research projects and enter into production with equipment suitable for a number of different market segments."
http://medizoneint.com/
http://medizoneint.com/medizone-international-secures-10000000-funding-commitment/